Changshu, China

Jun Cao

This inventor holds 3 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignee: Novartis Ag. Active years: 2015-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jun Cao. Retrieved from https://idiyas.com/inventor/jun-cao-7ji872jt

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 33.3

 

Average Co-Inventor Count = 13.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2015-2019

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Jun Cao: Innovator in Pharmaceutical Compounds

Introduction

Jun Cao is a notable inventor based in Changshu, China. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative compounds. With a total of three patents to his name, Cao's work is recognized for its therapeutic applications.

Latest Patents

One of Jun Cao's latest patents involves a Benzothiazolone compound. This invention provides a compound of formula (I) in free form or in pharmaceutically acceptable salt form. It also includes a method for manufacturing the compound and its therapeutic uses. Furthermore, the invention offers a combination of pharmacologically active agents and pharmaceutical compositions.

Career Highlights

Jun Cao is currently associated with Novartis AG, a leading global healthcare company. His work at Novartis has allowed him to focus on developing innovative solutions in the pharmaceutical industry. His contributions have been instrumental in advancing therapeutic options for various medical conditions.

Collaborations

Cao has collaborated with notable colleagues, including Bernhard Erb and Robin Alec Fairhurst. These partnerships have enhanced the scope and impact of his research and inventions.

Conclusion

Jun Cao's innovative work in pharmaceutical compounds exemplifies the importance of research and development in healthcare. His contributions continue to influence the industry and improve therapeutic options for patients.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…